These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8961139)

  • 1. Strategies for delivery of peptides utilizing absorption-enhancing agents.
    Fix JA
    J Pharm Sci; 1996 Dec; 85(12):1282-5. PubMed ID: 8961139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral peptide and protein delivery: intestinal obstacles and commercial prospects.
    Smart AL; Gaisford S; Basit AW
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1323-35. PubMed ID: 24816134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging trends in oral delivery of peptide and protein drugs.
    Mahato RI; Narang AS; Thoma L; Miller DD
    Crit Rev Ther Drug Carrier Syst; 2003; 20(2-3):153-214. PubMed ID: 14584523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral controlled release technology for peptides: status and future prospects.
    Fix JA
    Pharm Res; 1996 Dec; 13(12):1760-4. PubMed ID: 8987068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral peptide delivery: Translational challenges due to physiological effects.
    Tyagi P; Pechenov S; Anand Subramony J
    J Control Release; 2018 Oct; 287():167-176. PubMed ID: 30145135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Methodologies for regulation of intestinal absorption of biologically active peptides].
    Fujita T; Muranishi S
    Nihon Rinsho; 1998 Mar; 56(3):589-94. PubMed ID: 9549341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral delivery of peptide drugs: barriers and developments.
    Hamman JH; Enslin GM; Kotzé AF
    BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delivery system design for improvement of intestinal absorption of peptide drugs].
    Muranishi S
    Yakugaku Zasshi; 1997 Jul; 117(7):394-414. PubMed ID: 9261212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeation enhancers for oral peptide delivery.
    Maher S; Mrsny RJ; Brayden DJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):277-319. PubMed ID: 27320643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Models to predict intestinal absorption of therapeutic peptides and proteins.
    Antunes F; Andrade F; Ferreira D; Nielsen HM; Sarmento B
    Curr Drug Metab; 2013 Jan; 14(1):4-20. PubMed ID: 21933113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmembrane transport of peptide type compounds: prospects for oral delivery.
    Lipka E; Crison J; Amidon GL
    J Control Release; 1996 May; 39(2-3):121-9. PubMed ID: 11539926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein drug oral delivery: the recent progress.
    Lee HJ
    Arch Pharm Res; 2002 Oct; 25(5):572-84. PubMed ID: 12433186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oral delivery of peptides and proteins: established versus recently patented approaches.
    Rosenmayr-Templeton L
    Pharm Pat Anal; 2013 Jan; 2(1):125-45. PubMed ID: 24236975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
    Richard J
    Ther Deliv; 2017 Jul; 8(8):663-684. PubMed ID: 28730934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile Acid as an Effective Absorption Enhancer for Oral Delivery of Epidermal Growth Factor Receptor-Targeted Hybrid Peptide.
    Gaowa A; Horibe T; Kohno M; Kawakami K
    J Pharm Sci; 2018 May; 107(5):1322-1329. PubMed ID: 29273347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.